Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRPF19 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TXNDC15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTSC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCRN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AMZ2P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
TGFBR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DDB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PTPN4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC43A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR7113 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POLR3K - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LONRF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ITM2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GOT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FDFT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIP1R - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on